Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_assertion type Assertion NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_head.
- NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_assertion description "[In the Endothelial Protection, AT1 blockade and Cholesterol-Dependent Oxidative Stress (EPAS) trial, impact of independent or combined statin and AT1 receptor blocker therapy on endothelial expression of anti-atherosclerotic and proatherosclerotic genes and endothelial function in arteries of patients with coronary artery disease were tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_provenance.
- NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_assertion evidence source_evidence_literature NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_provenance.
- NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_assertion SIO_000772 16820589 NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_provenance.
- NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_assertion wasDerivedFrom befree-20150227 NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_provenance.
- NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_assertion wasGeneratedBy ECO_0000203 NP255087.RA4FNsyfFvgMBqYriNE-LJGuwCAkjG0U5OuOQDN-SkgQM130_provenance.